Dabernat H J, Buu-Hoï-Dang Van A, Delmas C, Bauriaud R
Ann Microbiol (Paris). 1979 May-Jun;130 A(4):461-7.
The activity of cefotaxime (HR756), a new semi-synthetic cephalosporin, was compared with the activity of ampicillin, carbenicillin, cephalothin, cephaloridine, cefazolin, cefamandole and cefoxitin against 247 strains of Haemophilus sp.; 20 of these strains produce a beta-lactam inactivating enzyme. The minimal inhibitoring concentrations were determined by the agar plate dilution technique. Cefotaxime is not only more active than any other cephalosporin but also than ampicillin, generally estimated the most active drug against Haemophilus sp. Bacteriostatic concentrations of cefotaxime which inhibit 50 and 95% of the strains (BSC50 and BSC95) were 0,009 microgram/ml and 0,03 microgram/ml, respectively, showing an activity 20 times superior to that of ampicillin. Cefotaxime activity was unaffected by the production of beta-lactamase.
将新型半合成头孢菌素头孢噻肟(HR756)的活性与氨苄西林、羧苄西林、头孢噻吩、头孢啶、头孢唑林、头孢孟多和头孢西丁对247株嗜血杆菌属菌株的活性进行了比较;其中20株菌株产生β-内酰胺失活酶。采用琼脂平板稀释技术测定最小抑菌浓度。头孢噻肟不仅比任何其他头孢菌素活性更强,而且比通常被认为是抗嗜血杆菌属最具活性的药物氨苄西林活性更强。抑制50%和95%菌株的头孢噻肟抑菌浓度(BSC50和BSC95)分别为0.009微克/毫升和0.03微克/毫升,其活性比氨苄西林高20倍。头孢噻肟的活性不受β-内酰胺酶产生的影响。